Top

Published in:

01-09-2016 | Letter

Diabetes remission off medications is not a suitable endpoint for comparing bariatric/metabolic surgery with pharmacotherapy. Reply to Halpern B, Cercato C, Mancini MC [letter]

Author: David E. Cummings

Published in: Diabetologia | Issue 9/2016

Excerpt

To the Editor: On behalf of the authors of the Calorie Reduction Or Surgery: Seeking to Reduce Obesity And Diabetes Study (CROSSROADS) [1], I sincerely thank Halpern et al for their thoughtful critique of our trial [2]. …

Cummings DE, Arterburn DE, Westbrook EO et al (2016) Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial. Diabetologia 59:945–953CrossRefPubMed

Halpern B, Cercato C, Mancini MC (2016) Diabetes remission off medications is not a suitable endpoint for comparing bariatric/metabolic surgery with pharmacotherapy. Diabetologia. doi:10.1007/s00125-016-4007-3

Rubino F, Nathan DM, Eckel RH et al (2016) Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Diabetes Care 39:861–877CrossRefPubMed

Cummings DE, Cohen RV (2016) Bariatric/metabolic surgery to treat type 2 diabetes in patients with a BMI <35 kg/m². Diabetes Care 39:924–933CrossRefPubMed

Batterham RL, Cummings DE (2016) Mechanisms of diabetes improvement following bariatric/metabolic surgery. Diabetes Care 39:893–901

Panunzi S, De Gaetano A, Carnicelli A, Mingrone G (2015) Predictors of remission of diabetes mellitus in severely obese individuals undergoing bariatric surgery: do BMI or procedure choice matter? A meta-analysis. Ann Surg 261:459–467CrossRefPubMed

Schauer PR, Bhatt DL, Kirwan JP et al (2014) Bariatric surgery versus intensive medical therapy for diabetes—3-year outcomes. N Engl J Med 370:2002–2013CrossRefPubMed

Sjöstrom L (2013) Review of the key results from the Swedish Obese Subjects (SOS) trial – a prospective controlled intervention study of bariatric surgery. J Intern Med 273:219–234

Schauer PR, Mingrone G, Ikramuddin S, Wolfe B (2016) Clinical outcomes of metabolic surgery: Efficacy of glycemic control, weight loss, remission of disease, and complications. Diabetes Care 39:902–911CrossRefPubMed

Title: Diabetes remission off medications is not a suitable endpoint for comparing bariatric/metabolic surgery with pharmacotherapy. Reply to Halpern B, Cercato C, Mancini MC [letter]
Author: David E. Cummings
Publication date: 01-09-2016
Publisher: Springer Berlin Heidelberg
Published in: Diabetologia / Issue 9/2016
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-016-4029-x

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Diabetes remission off medications is not a suitable endpoint for comparing bariatric/metabolic surgery with pharmacotherapy. Reply to Halpern B, Cercato C, Mancini MC [letter]

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 9/2016

Can genetic evidence help us to understand the fetal origins of type 2 diabetes?

Tetraspanin 7 autoantibodies in type 1 diabetes

Pancreatic perfusion and subsequent response to glucose in healthy individuals and patients with type 1 diabetes

The effect of sodium glucose cotransporter 2 inhibition with empagliflozin on microalbuminuria and macroalbuminuria in patients with type 2 diabetes